APOE and diabetic kidney disease: When 1,3-butanediol, a precursor of β-OHB,16 was administrated to HFD-fed Apo E-deficient mice, the treatment prevented renal histopathologic damage and renal dysfunction in the mice.9 The enhanced ketone body metabolism in the damaged kidney is, therefore, likely to be renoprotective in DKD.